The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 12,024.00
Ask: 12,028.00
Change: 36.00 (0.30%)
Spread: 4.00 (0.033%)
Open: 12,254.00
High: 12,256.00
Low: 12,018.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Week Ahead

Mon, 03rd Nov 2014 16:08

UK Earnings, Trading Statements Calendar
Tuesday, November 4 
Advanced Computer Software GroupHalf Year Results
Associated British FoodsFull Year Results
Legal & General GroupInterim Management Statement
GlencoreInterim Management Statement
Weir GroupInterim Management Statement
Hilton Food GroupInterim Management Statement
Imperial Tobacco GroupFull Year Results
Jardine Lloyd Thompson GroupInterim Management Statement
PersimmonInterim Management Statement
Unite GroupInterim Management Statement
OneSavings BankInterim Management Statement
888 HoldingsTrading Update
Wednesday, November 5 
Lancashire HoldingsQ3 Results
First DerivativesHalf Year Results
Avocet MiningInterim Management Statement
MeggittInterim Management Statement
Marks & Spencer GroupHalf Year Results
FirstGroupHalf Year Results
Mithras Investment TrustInterim Management Statement
Old MutualInterim Management Statement
JD WetherspoonInterim Management Statement
WincantonInterim Management Statement
HuntingHalf Year Results
MarshallsInterim Management Statement
Drax GroupInterim Management Statement
esure GroupInterim Management Statement
AlentInterim Management Statement
Thursday, November 6 
Promethean WorldInterim Management Statement
Tate & LyleHalf Year Results
Shanks GroupHalf Year Results
Dairy CrestHalf Year Results
Coca-Cola HBC AGQ3 Results
AstraZenecaQ3 Results
STV GroupInterim Management Statement
Croda InternationalInterim Management Statement
DS SmithTrading statement
Costain GroupInterim Management Statement
Intu PropertieInterim Management Statement
ExperianHalf Year Results
BeazleyInterim Management Statement
Cable & Wireless CommunicationsHalf Year Results
Halfords GroupHalf Year Results
InmarsatQ3 Results
London MiningInterim Management Statement
Randgold ResourcesQ3 Results
RightmoveInterim Management Statement
RSA Insurance GroupInterim Management Statement
SchrodersInterim Management Statement
SynthomerInterim Management Statement
WM Morrison SupermarketsInterim Management Statement
Hikma PharmaceuticalsInterim Management Statement
CobhamInterim Management Statement
Stock Spirits GroupInterim Management Statement
SuperGroupTrading statement
Friday, November 7 
Croda InternationalInterim Management Statement
Scottish Mortgage Investment TrustHalf Year Results
Spirax-Sarco EngineeringHalf Year Results
Ark Therapeutics GroupInterim Management Statement
Capital & RegionalInterim Management Statement
Rentokil InitialTrading statement
Admiral GroupInterim Management Statement
National GridHalf Year Results
Capital & Counties PropertiesInterim Management Statement
Bovis Homes GroupInterim Management Statement
Monday, November 10 
BATM Advanced CommunicationsInterim Management Statement
e2v technologiesHalf Year Results
Carrs Milling IndustriesFull Year Results
HammersonInterim Management Statement
LonminFull Year Results
Morgan Advanced MaterialsInterim Management Statement
Pacific HorizonInterim Management Statement
RedrowInterim Management Statement
Industrial Multi Property TrustInterim Management Statement
Aveva GroupHalf Year Results
Just RetirementInterim Management Statement
Macau Property Opportunities FundInterim Management Statement
  
Copyright 2014 Alliance News Limited. All Rights Reserved.
  

More News
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.